- Published on
Emergency and Acute Medicine – Tibial/Fibular Shaft Fracture
Tibial and fibular shaft fractures are common long bone injuries, often resulting from trauma ranging from low-energy twisting mechanisms to high-energy direct blows such as motor vehicle collisions. The tibia is particularly vulnerable due to its subcutaneous location, and approximately 80% of tibial fractures are associated with a fibular fracture. A significant proportion (around 24%) are open fractures, making soft tissue assessment critically important.
Fractures are classified based on location (proximal, midshaft, distal), pattern (spiral, transverse, oblique, comminuted), displacement, and degree of soft tissue injury. Open fractures are further categorized using the Gustilo–Anderson classification, which ranges from type I (minimal soft tissue injury) to type III (severe soft tissue damage, including neurovascular compromise).
The mechanism of injury provides important clues. Low-energy injuries (e.g., falls, sports, twisting forces) tend to produce spiral or oblique fractures, whereas high-energy trauma (e.g., pedestrian vs. vehicle, crush injuries) often results in transverse or comminuted fractures with significant soft tissue damage. In children, special patterns such as toddler fractures (spiral distal tibia fractures) and bicycle spoke injuries should be recognized, as well as the possibility of nonaccidental trauma.
Patients typically present with severe localized pain, inability to bear weight (especially with tibial involvement), swelling, and deformity. On examination, clinicians must carefully assess for neurovascular compromise, including pulses, sensation, and motor function. Injury to the peroneal nerve, particularly with proximal fibular fractures, may lead to foot drop.
A key and potentially limb-threatening complication is compartment syndrome, which occurs in up to 8% of tibial shaft fractures. It may develop hours after injury and is characterized by pain out of proportion to the injury, pain with passive stretch, and progressive neurologic deficits. Importantly, pulses are usually still present, so their presence does not exclude the diagnosis. Early recognition is critical, as delayed treatment can result in permanent muscle and nerve damage.
Diagnosis is confirmed with imaging, including anteroposterior and lateral radiographs of the leg, knee, and ankle. CT may be required for complex fractures, while MRI is useful for stress or pathologic fractures. If compartment syndrome is suspected, compartment pressure measurements are indicated, with pressures >30 mm Hg or a delta pressure <20 mm Hg suggesting the need for urgent fasciotomy.
Initial management follows trauma principles, prioritizing airway, breathing, and circulation. The affected limb should be immobilized in a well-padded long leg posterior splint with slight knee flexion. Pain control and ice are important, but elevation should be avoided if compartment syndrome is suspected, as it may reduce perfusion.
Open fractures require urgent management, including irrigation, sterile dressing, tetanus prophylaxis, and early administration of antibiotics. First-generation cephalosporins such as cefazolin are used for gram-positive coverage, with additional agents like gentamicin for severe (type III) injuries and penicillin for contamination with soil or farming environments.
Most unstable fractures, open fractures, or those with neurovascular compromise require admission and orthopedic consultation. Surgical options include external fixation or intramedullary nailing, which allows earlier mobilization. Stable, minimally displaced fractures may be managed conservatively with casting and close follow-up.
Important clinical pearls include the high risk of associated injuries in high-energy trauma (such as femoral fractures or head injury) and the relatively high incidence of deep vein thrombosis following tibial fractures. Above all, vigilance for compartment syndrome is essential, as early diagnosis can be limb-saving.
Tibial and fibular shaft fractures are common long bone injuries, often resulting from trauma ranging from low-energy twisting mechanisms to high-energy direct blows such as motor vehicle collisions. The tibia is particularly vulnerable due to its subcutaneous location, and approximately 80% of tibial fractures are associated with a fibular fracture. A significant proportion (around 24%) are open fractures, making soft tissue assessment critically important.
Fractures are classified based on location (proximal, midshaft, distal), pattern (spiral, transverse, oblique, comminuted), displacement, and degree of soft tissue injury. Open fractures are further categorized using the Gustilo–Anderson classification, which ranges from type I (minimal soft tissue injury) to type III (severe soft tissue damage, including neurovascular compromise).
The mechanism of injury provides important clues. Low-energy injuries (e.g., falls, sports, twisting forces) tend to produce spiral or oblique fractures, whereas high-energy trauma (e.g., pedestrian vs. vehicle, crush injuries) often results in transverse or comminuted fractures with significant soft tissue damage. In children, special patterns such as toddler fractures (spiral distal tibia fractures) and bicycle spoke injuries should be recognized, as well as the possibility of nonaccidental trauma.
Patients typically present with severe localized pain, inability to bear weight (especially with tibial involvement), swelling, and deformity. On examination, clinicians must carefully assess for neurovascular compromise, including pulses, sensation, and motor function. Injury to the peroneal nerve, particularly with proximal fibular fractures, may lead to foot drop.
A key and potentially limb-threatening complication is compartment syndrome, which occurs in up to 8% of tibial shaft fractures. It may develop hours after injury and is characterized by pain out of proportion to the injury, pain with passive stretch, and progressive neurologic deficits. Importantly, pulses are usually still present, so their presence does not exclude the diagnosis. Early recognition is critical, as delayed treatment can result in permanent muscle and nerve damage.
Diagnosis is confirmed with imaging, including anteroposterior and lateral radiographs of the leg, knee, and ankle. CT may be required for complex fractures, while MRI is useful for stress or pathologic fractures. If compartment syndrome is suspected, compartment pressure measurements are indicated, with pressures >30 mm Hg or a delta pressure <20 mm Hg suggesting the need for urgent fasciotomy.
Initial management follows trauma principles, prioritizing airway, breathing, and circulation. The affected limb should be immobilized in a well-padded long leg posterior splint with slight knee flexion. Pain control and ice are important, but elevation should be avoided if compartment syndrome is suspected, as it may reduce perfusion.
Open fractures require urgent management, including irrigation, sterile dressing, tetanus prophylaxis, and early administration of antibiotics. First-generation cephalosporins such as cefazolin are used for gram-positive coverage, with additional agents like gentamicin for severe (type III) injuries and penicillin for contamination with soil or farming environments.
Most unstable fractures, open fractures, or those with neurovascular compromise require admission and orthopedic consultation. Surgical options include external fixation or intramedullary nailing, which allows earlier mobilization. Stable, minimally displaced fractures may be managed conservatively with casting and close follow-up.
Important clinical pearls include the high risk of associated injuries in high-energy trauma (such as femoral fractures or head injury) and the relatively high incidence of deep vein thrombosis following tibial fractures. Above all, vigilance for compartment syndrome is essential, as early diagnosis can be limb-saving.
- Published on
Emergency and Acute Medicine - Tetanus
Tetanus is a life-threatening neurologic disease caused by a toxin-producing bacterium and is now rare in developed countries but remains common worldwide, particularly in regions with limited vaccination coverage. Although only a small number of cases occur annually in countries like the United States, the disease still carries a high mortality rate. Most cases occur in individuals who are unvaccinated, inadequately immunized, or have not received a booster within the past 10 years. The incubation period typically ranges from 48 hours to several weeks, and a shorter onset period is associated with a worse prognosis. Neonatal tetanus, often resulting from infection of the umbilical stump, remains a major cause of infant mortality in developing regions.
The disease is caused by Clostridium tetani, an anaerobic, spore-forming gram-positive bacterium found in soil and animal feces. Its spores are highly resistant and can survive in harsh environments for long periods. Infection occurs when spores enter a wound or devitalized tissue and germinate under anaerobic conditions. The organism produces tetanospasmin, a potent neurotoxin that interferes with inhibitory neurotransmitters such as GABA, leading to uncontrolled muscle contractions, rigidity, and autonomic dysfunction.
Clinically, tetanus most commonly presents as a generalized form, characterized initially by muscle stiffness and pain, especially involving the jaw (trismus). This progresses to the classic facial expression known as risus sardonicus and generalized muscle rigidity. Patients may develop severe muscle spasms, including opisthotonos (arching of the back), limb rigidity, and clenched fists. Respiratory compromise can occur due to diaphragmatic involvement. Autonomic instability, including fluctuations in blood pressure, arrhythmias, and hyperthermia, is a major cause of death and often develops later in the course.
Other forms include localized tetanus, which causes muscle spasms near the site of injury and may persist for months, and cephalic tetanus, which follows head injuries or ear infections and involves cranial nerve dysfunction. Neonatal tetanus presents in the first weeks of life with poor feeding, irritability, and generalized spasms, and carries an extremely high mortality rate.
Diagnosis is primarily clinical, based on characteristic signs such as trismus and muscle rigidity. Laboratory tests are not diagnostic but may help exclude other conditions or assess complications. Wound cultures for the organism are often negative, and cerebrospinal fluid is typically normal. Differential diagnoses include conditions such as strychnine poisoning, meningitis, encephalitis, dystonic drug reactions, and other causes of muscle rigidity or spasms.
Management requires urgent supportive care and focuses on three main goals: stabilization, neutralization of toxin, and eradication of the organism. Airway management is critical, and early intubation is often necessary due to the risk of respiratory compromise. Muscle spasms are treated with benzodiazepines, and severe cases may require additional agents such as dantrolene or neuromuscular blockade. Autonomic instability is difficult to manage and may require medications such as labetalol, magnesium, or sedatives.
Neutralization of unbound toxin is achieved with tetanus immune globulin, which should be administered as early as possible. However, it does not affect toxin already bound to the nervous system. Elimination of the bacteria is accomplished through wound debridement and antibiotic therapy, with metronidazole being the preferred agent.
Prevention is essential and relies on vaccination. Routine immunization begins in childhood, with booster doses recommended every 10 years. In the setting of wounds, vaccination status must be assessed, and tetanus prophylaxis provided as indicated. Importantly, natural infection does not confer immunity, so patients must still be vaccinated after recovery.
All patients with suspected generalized tetanus require admission to an intensive care unit due to the risk of rapid deterioration and life-threatening complications. Early recognition, aggressive supportive care, and timely administration of immune globulin and antibiotics are critical in improving outcomes.
Tetanus is a life-threatening neurologic disease caused by a toxin-producing bacterium and is now rare in developed countries but remains common worldwide, particularly in regions with limited vaccination coverage. Although only a small number of cases occur annually in countries like the United States, the disease still carries a high mortality rate. Most cases occur in individuals who are unvaccinated, inadequately immunized, or have not received a booster within the past 10 years. The incubation period typically ranges from 48 hours to several weeks, and a shorter onset period is associated with a worse prognosis. Neonatal tetanus, often resulting from infection of the umbilical stump, remains a major cause of infant mortality in developing regions.
The disease is caused by Clostridium tetani, an anaerobic, spore-forming gram-positive bacterium found in soil and animal feces. Its spores are highly resistant and can survive in harsh environments for long periods. Infection occurs when spores enter a wound or devitalized tissue and germinate under anaerobic conditions. The organism produces tetanospasmin, a potent neurotoxin that interferes with inhibitory neurotransmitters such as GABA, leading to uncontrolled muscle contractions, rigidity, and autonomic dysfunction.
Clinically, tetanus most commonly presents as a generalized form, characterized initially by muscle stiffness and pain, especially involving the jaw (trismus). This progresses to the classic facial expression known as risus sardonicus and generalized muscle rigidity. Patients may develop severe muscle spasms, including opisthotonos (arching of the back), limb rigidity, and clenched fists. Respiratory compromise can occur due to diaphragmatic involvement. Autonomic instability, including fluctuations in blood pressure, arrhythmias, and hyperthermia, is a major cause of death and often develops later in the course.
Other forms include localized tetanus, which causes muscle spasms near the site of injury and may persist for months, and cephalic tetanus, which follows head injuries or ear infections and involves cranial nerve dysfunction. Neonatal tetanus presents in the first weeks of life with poor feeding, irritability, and generalized spasms, and carries an extremely high mortality rate.
Diagnosis is primarily clinical, based on characteristic signs such as trismus and muscle rigidity. Laboratory tests are not diagnostic but may help exclude other conditions or assess complications. Wound cultures for the organism are often negative, and cerebrospinal fluid is typically normal. Differential diagnoses include conditions such as strychnine poisoning, meningitis, encephalitis, dystonic drug reactions, and other causes of muscle rigidity or spasms.
Management requires urgent supportive care and focuses on three main goals: stabilization, neutralization of toxin, and eradication of the organism. Airway management is critical, and early intubation is often necessary due to the risk of respiratory compromise. Muscle spasms are treated with benzodiazepines, and severe cases may require additional agents such as dantrolene or neuromuscular blockade. Autonomic instability is difficult to manage and may require medications such as labetalol, magnesium, or sedatives.
Neutralization of unbound toxin is achieved with tetanus immune globulin, which should be administered as early as possible. However, it does not affect toxin already bound to the nervous system. Elimination of the bacteria is accomplished through wound debridement and antibiotic therapy, with metronidazole being the preferred agent.
Prevention is essential and relies on vaccination. Routine immunization begins in childhood, with booster doses recommended every 10 years. In the setting of wounds, vaccination status must be assessed, and tetanus prophylaxis provided as indicated. Importantly, natural infection does not confer immunity, so patients must still be vaccinated after recovery.
All patients with suspected generalized tetanus require admission to an intensive care unit due to the risk of rapid deterioration and life-threatening complications. Early recognition, aggressive supportive care, and timely administration of immune globulin and antibiotics are critical in improving outcomes.
- Published on
Theophylline poisoning is a potentially life-threatening toxicologic emergency resulting from excessive levels of a methylxanthine drug commonly used for respiratory conditions. Its toxicity is primarily due to increased endogenous catecholamine release, antagonism of adenosine receptors, and inhibition of phosphodiesterase at high concentrations. These mechanisms lead to widespread stimulation of the cardiovascular and central nervous systems. Theophylline is available in both immediate-release and sustained-release formulations, with peak absorption occurring within 1–2 hours for immediate-release and up to 6–10 hours for sustained-release forms, which can delay toxicity.
Toxicity can occur in several patterns. Acute overdose refers to a large ingestion in a patient without prior exposure, whereas acute-on-chronic toxicity occurs when a patient already on therapy takes an excessive dose. Chronic toxicity develops gradually due to accumulation, often from drug interactions, organ dysfunction such as liver disease or heart failure, or repeated dosing errors. Importantly, chronic toxicity tends to cause severe symptoms at lower serum levels compared to acute overdose.
Clinically, theophylline poisoning affects multiple organ systems. Cardiovascular manifestations include sinus tachycardia, atrial and ventricular dysrhythmias, and in severe cases ventricular tachycardia due to β1 stimulation and adenosine antagonism. Hypotension may occur at very high levels due to β2-mediated vasodilation and can be resistant to standard treatments. Neurologically, patients may present with tremors, agitation, altered mental status, and seizures, which are a hallmark of severe toxicity and occur more frequently in chronic intoxication. Gastrointestinal symptoms are common, particularly persistent nausea and vomiting, which can be severe and refractory.
Metabolic abnormalities are also prominent, including hypokalemia due to intracellular potassium shift, hyperglycemia, leukocytosis, and metabolic acidosis with elevated lactate. Hypophosphatemia and hypomagnesemia may also occur. Sustained-release formulations may form pharmacobezoars in the gastrointestinal tract, delaying absorption and prolonging toxicity.
Diagnosis is confirmed by measuring serum theophylline levels, with concentrations ≥20 μg/mL considered toxic. Serial levels are essential to ensure that peak levels have been reached, especially with sustained-release products. Electrocardiographic monitoring is critical due to the high risk of dysrhythmias. Additional laboratory testing helps assess complications such as electrolyte disturbances and metabolic derangements.
Management begins with stabilization of airway, breathing, and circulation, along with cardiac monitoring. Intravenous fluids are administered for hypotension, and rate control for supraventricular tachyarrhythmias may require β-blockers or calcium channel blockers. Notably, adenosine is often ineffective because its action is antagonized by theophylline. Ventricular dysrhythmias are treated according to standard protocols. Seizures should be treated aggressively with benzodiazepines, as other agents such as phenytoin are ineffective and may worsen outcomes.
Gastrointestinal decontamination plays a major role in treatment. Activated charcoal is highly effective, particularly when given in multiple doses, as it enhances elimination by interrupting enterohepatic circulation. Whole-bowel irrigation may be used for sustained-release ingestions to remove unabsorbed drug. Antiemetics such as metoclopramide or ondansetron may be required for severe vomiting. Electrolyte abnormalities should be corrected cautiously, especially hypokalemia, to avoid rebound hyperkalemia as drug levels fall.
In severe cases, extracorporeal removal such as hemodialysis or hemoperfusion is indicated, particularly in patients with very high serum levels, refractory seizures, or significant dysrhythmias. These methods are highly effective due to theophylline’s pharmacokinetic properties.
Patients with severe toxicity, high serum levels, or complications such as seizures or refractory hypotension require intensive care admission. Those with mild symptoms may be discharged once serum levels are clearly decreasing and below toxic thresholds, provided they remain clinically stable. Close follow-up is necessary, especially in patients on chronic therapy, to adjust dosing and prevent recurrence.
A key point in theophylline poisoning is that seizures and tachydysrhythmias are major causes of morbidity and mortality, and early recognition with aggressive treatment significantly improves outcomes. Multi-dose activated charcoal remains one of the most effective interventions in enhancing drug elimination.
Toxicity can occur in several patterns. Acute overdose refers to a large ingestion in a patient without prior exposure, whereas acute-on-chronic toxicity occurs when a patient already on therapy takes an excessive dose. Chronic toxicity develops gradually due to accumulation, often from drug interactions, organ dysfunction such as liver disease or heart failure, or repeated dosing errors. Importantly, chronic toxicity tends to cause severe symptoms at lower serum levels compared to acute overdose.
Clinically, theophylline poisoning affects multiple organ systems. Cardiovascular manifestations include sinus tachycardia, atrial and ventricular dysrhythmias, and in severe cases ventricular tachycardia due to β1 stimulation and adenosine antagonism. Hypotension may occur at very high levels due to β2-mediated vasodilation and can be resistant to standard treatments. Neurologically, patients may present with tremors, agitation, altered mental status, and seizures, which are a hallmark of severe toxicity and occur more frequently in chronic intoxication. Gastrointestinal symptoms are common, particularly persistent nausea and vomiting, which can be severe and refractory.
Metabolic abnormalities are also prominent, including hypokalemia due to intracellular potassium shift, hyperglycemia, leukocytosis, and metabolic acidosis with elevated lactate. Hypophosphatemia and hypomagnesemia may also occur. Sustained-release formulations may form pharmacobezoars in the gastrointestinal tract, delaying absorption and prolonging toxicity.
Diagnosis is confirmed by measuring serum theophylline levels, with concentrations ≥20 μg/mL considered toxic. Serial levels are essential to ensure that peak levels have been reached, especially with sustained-release products. Electrocardiographic monitoring is critical due to the high risk of dysrhythmias. Additional laboratory testing helps assess complications such as electrolyte disturbances and metabolic derangements.
Management begins with stabilization of airway, breathing, and circulation, along with cardiac monitoring. Intravenous fluids are administered for hypotension, and rate control for supraventricular tachyarrhythmias may require β-blockers or calcium channel blockers. Notably, adenosine is often ineffective because its action is antagonized by theophylline. Ventricular dysrhythmias are treated according to standard protocols. Seizures should be treated aggressively with benzodiazepines, as other agents such as phenytoin are ineffective and may worsen outcomes.
Gastrointestinal decontamination plays a major role in treatment. Activated charcoal is highly effective, particularly when given in multiple doses, as it enhances elimination by interrupting enterohepatic circulation. Whole-bowel irrigation may be used for sustained-release ingestions to remove unabsorbed drug. Antiemetics such as metoclopramide or ondansetron may be required for severe vomiting. Electrolyte abnormalities should be corrected cautiously, especially hypokalemia, to avoid rebound hyperkalemia as drug levels fall.
In severe cases, extracorporeal removal such as hemodialysis or hemoperfusion is indicated, particularly in patients with very high serum levels, refractory seizures, or significant dysrhythmias. These methods are highly effective due to theophylline’s pharmacokinetic properties.
Patients with severe toxicity, high serum levels, or complications such as seizures or refractory hypotension require intensive care admission. Those with mild symptoms may be discharged once serum levels are clearly decreasing and below toxic thresholds, provided they remain clinically stable. Close follow-up is necessary, especially in patients on chronic therapy, to adjust dosing and prevent recurrence.
A key point in theophylline poisoning is that seizures and tachydysrhythmias are major causes of morbidity and mortality, and early recognition with aggressive treatment significantly improves outcomes. Multi-dose activated charcoal remains one of the most effective interventions in enhancing drug elimination.
- Published on
Emergency and Acute Medicine – Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura is a life-threatening hematologic emergency characterized by widespread microvascular thrombosis leading to multiorgan ischemia. It is classically described by a pentad consisting of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, renal dysfunction, and fever, although most patients do not present with all five features. The most consistent findings are thrombocytopenia and hemolytic anemia, and the presence of these two findings alone is sufficient to strongly suspect the diagnosis and initiate treatment.
The underlying pathophysiology involves a deficiency of the enzyme ADAMTS13, which normally cleaves large multimers of von Willebrand factor. Without this enzyme, unusually large vWF multimers promote platelet aggregation and formation of microthrombi within small vessels. These thrombi consume platelets and mechanically shear red blood cells, resulting in hemolysis. The widespread microvascular occlusion leads to ischemia in multiple organs, particularly the brain, kidneys, and heart.
TTP can occur in several forms, including idiopathic, hereditary, drug-induced, pregnancy-associated, or secondary to infections or malignancy. It most commonly affects adults between the third and sixth decades of life and is more frequent in women. Without treatment, mortality exceeds 90%, but with modern therapy, survival rates exceed 90%, making early recognition and intervention critical.
Patients often present with nonspecific symptoms such as fatigue, weakness, and fever, along with signs of bleeding like petechiae, purpura, or mucosal hemorrhage. Neurologic manifestations are common and may include confusion, headache, seizures, or focal deficits, often fluctuating in severity. Renal involvement is usually mild compared to hemolytic uremic syndrome but may include hematuria and elevated creatinine.
Diagnosis is primarily clinical and should not be delayed while awaiting confirmatory tests. Laboratory findings typically show anemia with elevated reticulocyte count, severe thrombocytopenia, elevated lactate dehydrogenase due to hemolysis and tissue ischemia, and increased indirect bilirubin. Peripheral blood smear demonstrates schistocytes, which are fragmented red blood cells. Coagulation studies are usually normal, helping to distinguish TTP from disseminated intravascular coagulation. ADAMTS13 testing may support the diagnosis but is not required to initiate treatment.
Management is a medical emergency and begins with stabilization of airway, breathing, and circulation. The cornerstone of treatment is urgent plasma exchange therapy, which removes circulating autoantibodies and replenishes functional ADAMTS13. Plasma exchange is performed daily until platelet counts normalize and clinical improvement is observed. Fresh frozen plasma may be used as a temporary measure if exchange is not immediately available.
Supportive care includes red blood cell transfusion for significant anemia, while platelet transfusion is generally avoided unless there is life-threatening bleeding, as it may worsen thrombosis. Corticosteroids are often used to reduce immune-mediated damage, and additional therapies such as rituximab may be considered in refractory or relapsing cases. Dialysis may be required in cases of significant renal failure.
Patients require hospital admission, often to an intensive care setting, particularly if neurologic symptoms or bleeding are present. Early diagnosis and prompt initiation of plasma exchange are the most important factors in improving survival. A key clinical principle is that treatment should begin as soon as TTP is suspected, even before confirmatory testing, due to the rapid progression and high mortality of untreated disease.
Thrombotic thrombocytopenic purpura is a life-threatening hematologic emergency characterized by widespread microvascular thrombosis leading to multiorgan ischemia. It is classically described by a pentad consisting of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, renal dysfunction, and fever, although most patients do not present with all five features. The most consistent findings are thrombocytopenia and hemolytic anemia, and the presence of these two findings alone is sufficient to strongly suspect the diagnosis and initiate treatment.
The underlying pathophysiology involves a deficiency of the enzyme ADAMTS13, which normally cleaves large multimers of von Willebrand factor. Without this enzyme, unusually large vWF multimers promote platelet aggregation and formation of microthrombi within small vessels. These thrombi consume platelets and mechanically shear red blood cells, resulting in hemolysis. The widespread microvascular occlusion leads to ischemia in multiple organs, particularly the brain, kidneys, and heart.
TTP can occur in several forms, including idiopathic, hereditary, drug-induced, pregnancy-associated, or secondary to infections or malignancy. It most commonly affects adults between the third and sixth decades of life and is more frequent in women. Without treatment, mortality exceeds 90%, but with modern therapy, survival rates exceed 90%, making early recognition and intervention critical.
Patients often present with nonspecific symptoms such as fatigue, weakness, and fever, along with signs of bleeding like petechiae, purpura, or mucosal hemorrhage. Neurologic manifestations are common and may include confusion, headache, seizures, or focal deficits, often fluctuating in severity. Renal involvement is usually mild compared to hemolytic uremic syndrome but may include hematuria and elevated creatinine.
Diagnosis is primarily clinical and should not be delayed while awaiting confirmatory tests. Laboratory findings typically show anemia with elevated reticulocyte count, severe thrombocytopenia, elevated lactate dehydrogenase due to hemolysis and tissue ischemia, and increased indirect bilirubin. Peripheral blood smear demonstrates schistocytes, which are fragmented red blood cells. Coagulation studies are usually normal, helping to distinguish TTP from disseminated intravascular coagulation. ADAMTS13 testing may support the diagnosis but is not required to initiate treatment.
Management is a medical emergency and begins with stabilization of airway, breathing, and circulation. The cornerstone of treatment is urgent plasma exchange therapy, which removes circulating autoantibodies and replenishes functional ADAMTS13. Plasma exchange is performed daily until platelet counts normalize and clinical improvement is observed. Fresh frozen plasma may be used as a temporary measure if exchange is not immediately available.
Supportive care includes red blood cell transfusion for significant anemia, while platelet transfusion is generally avoided unless there is life-threatening bleeding, as it may worsen thrombosis. Corticosteroids are often used to reduce immune-mediated damage, and additional therapies such as rituximab may be considered in refractory or relapsing cases. Dialysis may be required in cases of significant renal failure.
Patients require hospital admission, often to an intensive care setting, particularly if neurologic symptoms or bleeding are present. Early diagnosis and prompt initiation of plasma exchange are the most important factors in improving survival. A key clinical principle is that treatment should begin as soon as TTP is suspected, even before confirmatory testing, due to the rapid progression and high mortality of untreated disease.
- Published on
Emergency and Acute Medicine – Tibial Plateau Fracture
Tibial plateau fractures are serious intra-articular injuries involving the proximal tibia that can compromise knee stability and function. These fractures occur when axial loading is combined with valgus or varus forces, leading to splitting or depression of the articular surface. They are commonly classified using the Schatzker system, which ranges from low-energy lateral plateau fractures (types 1–3) to high-energy bicondylar and comminuted fractures (types 4–6), the latter often associated with significant soft tissue, ligamentous, and neurovascular injuries.
The mechanism of injury varies with fracture type. Low-energy injuries, such as those seen in sports or minor trauma, often produce lateral plateau fractures, particularly in younger individuals or those with relatively strong bone. In contrast, high-energy mechanisms such as motor vehicle collisions or falls from height tend to produce more severe medial or bicondylar fractures and are frequently associated with complications such as popliteal artery injury, peroneal nerve damage, and compartment syndrome.
Clinically, patients present with knee pain, swelling, and inability to bear weight. Examination may reveal joint effusion, limited range of motion, tenderness over the proximal tibia, and possible deformity or instability of the knee. A thorough neurovascular examination is essential, particularly in high-energy injuries, as vascular compromise or nerve injury can have limb-threatening consequences. Findings such as diminished pulses, sensory deficits, or weakness in ankle dorsiflexion should raise concern for serious complications.
Radiographic evaluation begins with plain X-rays, including specialized views to assess the tibial plateau and joint surface. Findings may include fracture lines, depression of the articular surface, or lipohemarthrosis, which is highly suggestive of an intra-articular fracture. Computed tomography is often used to better characterize fracture patterns, while MRI may be helpful in identifying associated ligamentous or meniscal injuries. In cases of suspected vascular injury, arteriography may be indicated but should not delay urgent intervention.
Initial management focuses on stabilization, pain control, and prevention of further injury. The affected limb should be immobilized in a long leg splint with the knee in extension, and the patient should remain non–weight bearing. Ice and elevation are important to reduce swelling. In cases of open fractures, prompt antibiotic administration, tetanus prophylaxis, and surgical consultation are required.
Stable, minimally displaced fractures without ligamentous injury may be managed conservatively with immobilization and close follow-up. However, unstable fractures, those with significant displacement, or injuries associated with vascular compromise or compartment syndrome require urgent orthopedic evaluation and often surgical intervention. High-energy injuries may also require hospital admission for monitoring due to the risk of delayed compartment syndrome.
A key clinical consideration is the potential for associated popliteal artery injury in high-energy mechanisms, which can be limb-threatening if missed. Additionally, tibial plateau fractures can be subtle on initial imaging, and a high index of suspicion is necessary, particularly when clinical findings are disproportionate to radiographic results.
Tibial plateau fractures are serious intra-articular injuries involving the proximal tibia that can compromise knee stability and function. These fractures occur when axial loading is combined with valgus or varus forces, leading to splitting or depression of the articular surface. They are commonly classified using the Schatzker system, which ranges from low-energy lateral plateau fractures (types 1–3) to high-energy bicondylar and comminuted fractures (types 4–6), the latter often associated with significant soft tissue, ligamentous, and neurovascular injuries.
The mechanism of injury varies with fracture type. Low-energy injuries, such as those seen in sports or minor trauma, often produce lateral plateau fractures, particularly in younger individuals or those with relatively strong bone. In contrast, high-energy mechanisms such as motor vehicle collisions or falls from height tend to produce more severe medial or bicondylar fractures and are frequently associated with complications such as popliteal artery injury, peroneal nerve damage, and compartment syndrome.
Clinically, patients present with knee pain, swelling, and inability to bear weight. Examination may reveal joint effusion, limited range of motion, tenderness over the proximal tibia, and possible deformity or instability of the knee. A thorough neurovascular examination is essential, particularly in high-energy injuries, as vascular compromise or nerve injury can have limb-threatening consequences. Findings such as diminished pulses, sensory deficits, or weakness in ankle dorsiflexion should raise concern for serious complications.
Radiographic evaluation begins with plain X-rays, including specialized views to assess the tibial plateau and joint surface. Findings may include fracture lines, depression of the articular surface, or lipohemarthrosis, which is highly suggestive of an intra-articular fracture. Computed tomography is often used to better characterize fracture patterns, while MRI may be helpful in identifying associated ligamentous or meniscal injuries. In cases of suspected vascular injury, arteriography may be indicated but should not delay urgent intervention.
Initial management focuses on stabilization, pain control, and prevention of further injury. The affected limb should be immobilized in a long leg splint with the knee in extension, and the patient should remain non–weight bearing. Ice and elevation are important to reduce swelling. In cases of open fractures, prompt antibiotic administration, tetanus prophylaxis, and surgical consultation are required.
Stable, minimally displaced fractures without ligamentous injury may be managed conservatively with immobilization and close follow-up. However, unstable fractures, those with significant displacement, or injuries associated with vascular compromise or compartment syndrome require urgent orthopedic evaluation and often surgical intervention. High-energy injuries may also require hospital admission for monitoring due to the risk of delayed compartment syndrome.
A key clinical consideration is the potential for associated popliteal artery injury in high-energy mechanisms, which can be limb-threatening if missed. Additionally, tibial plateau fractures can be subtle on initial imaging, and a high index of suspicion is necessary, particularly when clinical findings are disproportionate to radiographic results.
- Published on
Emergency and Acute Medicine – Thoracic Outlet Syndrome
Thoracic outlet syndrome refers to a group of conditions caused by compression of neurovascular structures—the brachial plexus, subclavian vein, or subclavian artery—as they pass from the neck into the upper extremity. This compression occurs in the thoracic outlet, a narrow space bordered by the clavicle, first rib, and surrounding muscles. The condition is classified into three types based on the structure involved: neurogenic, venous, and arterial, with neurogenic being by far the most common, accounting for over 90% of cases.
The underlying causes are often related to anatomic abnormalities or external stressors. Congenital variations such as a cervical rib or abnormal first rib can predispose individuals to compression. Trauma, particularly whiplash injuries, and repetitive overhead activities are common contributors, especially in neurogenic cases. Venous thoracic outlet syndrome is often associated with effort-related thrombosis of the subclavian vein, particularly in young athletes, while arterial thoracic outlet syndrome is usually linked to structural abnormalities that lead to arterial compression, aneurysm formation, or distal embolization.
Symptoms vary depending on the type involved. Neurogenic thoracic outlet syndrome typically presents with pain, numbness, tingling, and weakness affecting the shoulder, arm, and hand. In more advanced cases, there may be muscle wasting of the hand, particularly in the thenar region. Venous thoracic outlet syndrome is characterized by swelling of the arm, cyanosis, and a feeling of heaviness, reflecting impaired venous return. Arterial thoracic outlet syndrome presents with signs of limb ischemia, including pallor, coldness, pain, and claudication, especially during activity, and may occasionally present with a pulsatile mass if an aneurysm is present.
Diagnosis relies heavily on clinical evaluation, as there is no single definitive test, especially for neurogenic cases. A detailed history often reveals positional symptoms or exacerbation with repetitive overhead use. Physical examination may include provocative maneuvers such as the Roos test, Adson test, or Wright test, although these are neither highly sensitive nor specific. A significant blood pressure difference between arms may suggest arterial involvement.
Imaging and additional testing are guided by suspected subtype. Chest radiographs can identify bony abnormalities such as a cervical rib. Ultrasound is useful for detecting venous thrombosis, while duplex scanning can assess arterial flow and identify aneurysms or stenosis. More advanced imaging such as MRI or angiography may be required in selected cases, particularly when planning surgical intervention or excluding alternative diagnoses.
Management depends on severity and type. Most patients with neurogenic thoracic outlet syndrome improve with conservative therapy, including physical therapy, posture correction, and pain management with medications such as NSAIDs or muscle relaxants. In contrast, vascular forms require more urgent intervention. Venous thrombosis is treated with anticoagulation and often thrombolysis, followed by surgical decompression. Arterial involvement, particularly with ischemia or aneurysm, typically necessitates surgical repair.
Disposition depends on the presence of complications. Patients with limb-threatening ischemia, thrombosis, or severe symptoms require admission and specialist consultation, while those with mild neurogenic symptoms can often be managed as outpatients with close follow-up. Early recognition is important because untreated vascular thoracic outlet syndrome can lead to significant morbidity, including permanent limb damage.
Thoracic outlet syndrome refers to a group of conditions caused by compression of neurovascular structures—the brachial plexus, subclavian vein, or subclavian artery—as they pass from the neck into the upper extremity. This compression occurs in the thoracic outlet, a narrow space bordered by the clavicle, first rib, and surrounding muscles. The condition is classified into three types based on the structure involved: neurogenic, venous, and arterial, with neurogenic being by far the most common, accounting for over 90% of cases.
The underlying causes are often related to anatomic abnormalities or external stressors. Congenital variations such as a cervical rib or abnormal first rib can predispose individuals to compression. Trauma, particularly whiplash injuries, and repetitive overhead activities are common contributors, especially in neurogenic cases. Venous thoracic outlet syndrome is often associated with effort-related thrombosis of the subclavian vein, particularly in young athletes, while arterial thoracic outlet syndrome is usually linked to structural abnormalities that lead to arterial compression, aneurysm formation, or distal embolization.
Symptoms vary depending on the type involved. Neurogenic thoracic outlet syndrome typically presents with pain, numbness, tingling, and weakness affecting the shoulder, arm, and hand. In more advanced cases, there may be muscle wasting of the hand, particularly in the thenar region. Venous thoracic outlet syndrome is characterized by swelling of the arm, cyanosis, and a feeling of heaviness, reflecting impaired venous return. Arterial thoracic outlet syndrome presents with signs of limb ischemia, including pallor, coldness, pain, and claudication, especially during activity, and may occasionally present with a pulsatile mass if an aneurysm is present.
Diagnosis relies heavily on clinical evaluation, as there is no single definitive test, especially for neurogenic cases. A detailed history often reveals positional symptoms or exacerbation with repetitive overhead use. Physical examination may include provocative maneuvers such as the Roos test, Adson test, or Wright test, although these are neither highly sensitive nor specific. A significant blood pressure difference between arms may suggest arterial involvement.
Imaging and additional testing are guided by suspected subtype. Chest radiographs can identify bony abnormalities such as a cervical rib. Ultrasound is useful for detecting venous thrombosis, while duplex scanning can assess arterial flow and identify aneurysms or stenosis. More advanced imaging such as MRI or angiography may be required in selected cases, particularly when planning surgical intervention or excluding alternative diagnoses.
Management depends on severity and type. Most patients with neurogenic thoracic outlet syndrome improve with conservative therapy, including physical therapy, posture correction, and pain management with medications such as NSAIDs or muscle relaxants. In contrast, vascular forms require more urgent intervention. Venous thrombosis is treated with anticoagulation and often thrombolysis, followed by surgical decompression. Arterial involvement, particularly with ischemia or aneurysm, typically necessitates surgical repair.
Disposition depends on the presence of complications. Patients with limb-threatening ischemia, thrombosis, or severe symptoms require admission and specialist consultation, while those with mild neurogenic symptoms can often be managed as outpatients with close follow-up. Early recognition is important because untreated vascular thoracic outlet syndrome can lead to significant morbidity, including permanent limb damage.
- Published on
Emergency and Acute Medicine – Syncope
Syncope is a transient loss of consciousness associated with loss of postural tone, caused by temporary cerebral hypoperfusion, particularly affecting the brainstem reticular activating system. It is most often due to a sudden drop in cardiac output, after which cerebral perfusion is restored through autonomic mechanisms and the supine position following collapse. Syncope accounts for approximately 3% of emergency department visits.
Syncope can occur in special populations with unique considerations. In pregnancy, presyncope and syncope are common due to decreased systemic vascular resistance from the placenta acting like an arteriovenous shunt, as well as compression of the inferior vena cava by the fetus. However, serious conditions such as pulmonary embolism, preeclampsia, and cardiac disease must always be excluded. In elderly patients, syncope is more frequent and often multifactorial, with higher morbidity and multiple contributing causes.
The causes of syncope are broadly categorized. Neurally mediated syncope, such as vasovagal syncope, is the most common and results from reflex vasodilation and bradycardia, often triggered by pain, fear, or emotional stress, and usually preceded by prodromal symptoms. Carotid sinus hypersensitivity may be triggered by actions such as coughing, sneezing, or micturition. Orthostatic syncope results from a sudden drop in venous return due to positional change and may be caused by dehydration, hemorrhage, autonomic dysfunction (such as diabetic neuropathy), or medications. Cardiac causes include arrhythmias, which often present suddenly without warning, and structural heart disease such as aortic stenosis, hypertrophic cardiomyopathy, myocardial infarction, pulmonary embolism, or aortic dissection. Neurologic causes are less common but include conditions such as subarachnoid hemorrhage or cerebrovascular insufficiency.
Patients often report prodromal symptoms such as lightheadedness, diaphoresis, nausea, dimming vision, and weakness. Features that suggest a life-threatening cause include sudden loss of consciousness without warning, chest pain, or palpitations. A structured history using the “6 Ps” (preprodrome, prodrome, predisposing factors, precipitating factors, passerby account, and postictal phase) can help determine the etiology. A postictal phase suggests seizure rather than syncope. Physical examination should include assessment for trauma, orthostatic vital signs, cardiovascular examination for murmurs or arrhythmias, neurologic evaluation, and screening for possible bleeding or pregnancy. In children, concerning features include syncope during exertion, events triggered by loud noise or stress, occurrence while supine, or a family history of sudden death.
Evaluation relies heavily on history and physical examination, which can determine the diagnosis in most cases. An ECG should be performed immediately to assess for ischemia, arrhythmias, conduction abnormalities, long QT syndrome, Brugada syndrome, or pre-excitation syndromes. Laboratory testing is guided by clinical suspicion and may include complete blood count for anemia or bleeding, electrolytes, cardiac enzymes, and pregnancy testing. Imaging such as chest radiography, CT angiography, or head CT is reserved for suspected cardiopulmonary or neurologic causes. Echocardiography is useful when structural heart disease is suspected.
Management begins with stabilization, including airway, breathing, and circulation, oxygen supplementation, cardiac monitoring, and intravenous access. Fluid resuscitation is indicated in suspected hypovolemia. In unstable patients, advanced cardiac life support protocols should be followed. Treatment is directed at the underlying cause, such as managing arrhythmias, treating myocardial infarction, controlling blood pressure in aortic dissection or subarachnoid hemorrhage, or administering thrombolytics for pulmonary embolism when appropriate. In cases of persistent altered mental status, a “coma cocktail” including dextrose, thiamine, and naloxone may be considered.
Disposition depends on risk stratification. High-risk patients, such as those identified by the San Francisco Syncope Rule (history of congestive heart failure, hematocrit <30%, abnormal ECG, shortness of breath, or systolic blood pressure <90 mm Hg), should be admitted for monitoring. Patients with suspected cardiac causes or significant comorbidities also require admission. Low-risk patients with vasovagal or orthostatic syncope may be discharged with close follow-up, provided they are reliable and have adequate support. Driving restrictions should be advised until evaluation is complete.
Syncope is frequently confused with seizure, but the presence of postictal confusion strongly favors seizure. Brief tonic movements or urinary incontinence may still occur in syncope. Clinicians should avoid assuming a benign vasovagal cause when syncope is associated with chest pain or headache, as these may indicate serious underlying conditions.
- Published on
Emergency and Acute Medicine - Syphilis
Syphilis is a sexually transmitted infection caused by the spirochete bacterium Treponema pallidum. It is acquired through contact with infected mucous membranes or disrupted skin and remains a significant global health issue, with millions of new cases diagnosed annually. The disease progresses through distinct stages—primary, secondary, latent, and tertiary—each with characteristic clinical features.
Primary syphilis typically presents after an incubation period of about three weeks. The hallmark lesion is a painless chancre at the site of inoculation, which appears as a clean-based, well-demarcated ulcer, usually on the genitalia, rectum, or oral mucosa. Regional lymphadenopathy is common, and the lesion heals spontaneously within three to six weeks, often leading to missed diagnosis if not recognized early.
Secondary syphilis develops several weeks after the primary stage due to hematogenous dissemination of the organism. It is characterized by a diffuse, symmetric rash that often involves the palms and soles, a key diagnostic clue. Lesions may be maculopapular, papular, or polymorphic. Other features include mucous patches, condyloma lata (broad, moist, highly infectious lesions in intertriginous areas), generalized lymphadenopathy, and systemic symptoms such as fever, malaise, sore throat, and weight loss. Less common findings include patchy “moth-eaten” alopecia and ocular or neurologic involvement. This stage also resolves spontaneously if untreated.
Following resolution of secondary symptoms, the disease enters a latent phase, during which patients are asymptomatic but serologically positive. Early latent syphilis remains potentially infectious, while late latent syphilis is generally not, except in pregnancy where vertical transmission can occur. Without treatment, a subset of patients progress to tertiary syphilis years to decades later.
Tertiary syphilis is a destructive phase that may involve multiple organ systems. Neurosyphilis is the most common manifestation and can present with meningitis, cranial nerve deficits, dementia, or tabes dorsalis, which involves degeneration of the spinal cord leading to sensory loss and gait abnormalities. Cardiovascular syphilis may cause aortic aneurysm or aortic valve insufficiency. Gummatous syphilis results in granulomatous lesions affecting skin, bone, or internal organs. Syphilis is often called the “great imitator” because its manifestations can resemble many other diseases.
Congenital syphilis occurs when infection is transmitted in utero. Infants may present with hepatosplenomegaly, rash, jaundice, and nasal discharge (“snuffles”), while older children may develop characteristic deformities such as Hutchinson teeth, saddle nose, and hearing loss.
Diagnosis relies primarily on serologic testing. Nontreponemal tests such as rapid plasma reagin (RPR) or Venereal Disease Research Laboratory (VDRL) are used for screening and monitoring treatment response, while treponemal tests such as fluorescent treponemal antibody absorption (FTA-ABS) confirm the diagnosis and remain positive for life. Dark-field microscopy can identify organisms in early lesions, and cerebrospinal fluid analysis is required when neurosyphilis is suspected.
Treatment is centered on penicillin, which remains the gold standard. Early stages are treated with a single intramuscular dose of benzathine penicillin G, while late latent disease requires multiple doses over several weeks. Neurosyphilis requires intravenous penicillin therapy. Patients allergic to penicillin, particularly pregnant women, should undergo desensitization. A Jarisch–Herxheimer reaction, characterized by fever and worsening symptoms shortly after treatment, may occur but is self-limited.
Follow-up is essential to ensure treatment success, with serial monitoring of antibody titers over time. Sexual partners should be tested and treated as necessary, and patients should also be screened for other sexually transmitted infections, including HIV. Early recognition and treatment are critical to prevent progression to late-stage disease and its serious complications.
Syphilis is a sexually transmitted infection caused by the spirochete bacterium Treponema pallidum. It is acquired through contact with infected mucous membranes or disrupted skin and remains a significant global health issue, with millions of new cases diagnosed annually. The disease progresses through distinct stages—primary, secondary, latent, and tertiary—each with characteristic clinical features.
Primary syphilis typically presents after an incubation period of about three weeks. The hallmark lesion is a painless chancre at the site of inoculation, which appears as a clean-based, well-demarcated ulcer, usually on the genitalia, rectum, or oral mucosa. Regional lymphadenopathy is common, and the lesion heals spontaneously within three to six weeks, often leading to missed diagnosis if not recognized early.
Secondary syphilis develops several weeks after the primary stage due to hematogenous dissemination of the organism. It is characterized by a diffuse, symmetric rash that often involves the palms and soles, a key diagnostic clue. Lesions may be maculopapular, papular, or polymorphic. Other features include mucous patches, condyloma lata (broad, moist, highly infectious lesions in intertriginous areas), generalized lymphadenopathy, and systemic symptoms such as fever, malaise, sore throat, and weight loss. Less common findings include patchy “moth-eaten” alopecia and ocular or neurologic involvement. This stage also resolves spontaneously if untreated.
Following resolution of secondary symptoms, the disease enters a latent phase, during which patients are asymptomatic but serologically positive. Early latent syphilis remains potentially infectious, while late latent syphilis is generally not, except in pregnancy where vertical transmission can occur. Without treatment, a subset of patients progress to tertiary syphilis years to decades later.
Tertiary syphilis is a destructive phase that may involve multiple organ systems. Neurosyphilis is the most common manifestation and can present with meningitis, cranial nerve deficits, dementia, or tabes dorsalis, which involves degeneration of the spinal cord leading to sensory loss and gait abnormalities. Cardiovascular syphilis may cause aortic aneurysm or aortic valve insufficiency. Gummatous syphilis results in granulomatous lesions affecting skin, bone, or internal organs. Syphilis is often called the “great imitator” because its manifestations can resemble many other diseases.
Congenital syphilis occurs when infection is transmitted in utero. Infants may present with hepatosplenomegaly, rash, jaundice, and nasal discharge (“snuffles”), while older children may develop characteristic deformities such as Hutchinson teeth, saddle nose, and hearing loss.
Diagnosis relies primarily on serologic testing. Nontreponemal tests such as rapid plasma reagin (RPR) or Venereal Disease Research Laboratory (VDRL) are used for screening and monitoring treatment response, while treponemal tests such as fluorescent treponemal antibody absorption (FTA-ABS) confirm the diagnosis and remain positive for life. Dark-field microscopy can identify organisms in early lesions, and cerebrospinal fluid analysis is required when neurosyphilis is suspected.
Treatment is centered on penicillin, which remains the gold standard. Early stages are treated with a single intramuscular dose of benzathine penicillin G, while late latent disease requires multiple doses over several weeks. Neurosyphilis requires intravenous penicillin therapy. Patients allergic to penicillin, particularly pregnant women, should undergo desensitization. A Jarisch–Herxheimer reaction, characterized by fever and worsening symptoms shortly after treatment, may occur but is self-limited.
Follow-up is essential to ensure treatment success, with serial monitoring of antibody titers over time. Sexual partners should be tested and treated as necessary, and patients should also be screened for other sexually transmitted infections, including HIV. Early recognition and treatment are critical to prevent progression to late-stage disease and its serious complications.
- Published on
Emergency and Acute Medicine - Tachydysrhythmias
Tachydysrhythmias refer to any disturbance of cardiac rhythm resulting in a heart rate greater than 100 beats per minute. They encompass a broad spectrum of arrhythmias originating from different parts of the cardiac conduction system, ranging from relatively benign sinus tachycardia to life-threatening ventricular fibrillation. The classification is typically based on the origin of the rhythm and the width of the QRS complex, distinguishing between supraventricular and ventricular causes.
Sinus tachycardia is a narrow-complex, regular rhythm usually between 100 and 150 beats per minute and represents a physiologic response to stressors such as hypovolemia, hypoxia, pain, anxiety, infection, or anemia. It results from increased sympathetic activity or reduced vagal tone and should prompt evaluation for an underlying cause rather than primary rhythm management.
Supraventricular tachycardias (SVTs) originate above the His bundle and may be regular or irregular. Regular SVTs include atrial tachycardia and junctional tachycardia, while irregular SVTs include atrial fibrillation, atrial flutter, and multifocal atrial tachycardia. Atrial fibrillation is the most common pathologic SVT encountered in emergency settings and is characterized by an irregularly irregular rhythm without distinct P waves. Atrial flutter typically demonstrates a sawtooth pattern on ECG. These rhythms are often associated with conditions such as hypertension, coronary artery disease, valvular disease, pulmonary disorders, or metabolic abnormalities.
Ventricular tachycardia (VT) is defined as three or more consecutive ventricular beats at a rate exceeding 100 beats per minute and is commonly associated with structural heart disease, particularly prior myocardial infarction. It may present as monomorphic or polymorphic VT and can rapidly deteriorate into ventricular fibrillation (VF), a chaotic rhythm with no effective cardiac output and a leading cause of sudden cardiac death. Torsades de pointes is a specific form of polymorphic VT associated with prolonged QT interval and is often triggered by medications or electrolyte imbalances such as hypokalemia or hypomagnesemia.
Clinical presentation varies widely, ranging from asymptomatic episodes to severe symptoms such as palpitations, dizziness, dyspnea, chest pain, syncope, or cardiac arrest. Signs of hemodynamic instability include hypotension, altered mental status, chest pain, and pulmonary edema, and these findings necessitate immediate intervention. A careful history and physical examination should focus on identifying underlying cardiac disease, triggers, and the stability of the patient.
Evaluation begins with assessment of airway, breathing, and circulation, followed by rapid determination of whether the patient is stable or unstable. A 12-lead ECG is essential to classify the rhythm and guide management. Laboratory testing is directed toward identifying underlying causes such as electrolyte disturbances, ischemia, or metabolic abnormalities.
Management depends primarily on the patient’s hemodynamic status and the type of rhythm. Unstable patients require immediate synchronized cardioversion for most tachydysrhythmias or defibrillation in cases of pulseless VT or VF, following advanced cardiac life support protocols. Stable patients with narrow-complex tachycardias may respond to vagal maneuvers or pharmacologic therapy such as adenosine. Atrial fibrillation and flutter are typically managed with rate control using beta-blockers or calcium channel blockers, with consideration of anticoagulation depending on duration and risk factors.
Wide-complex tachycardias should be presumed to be ventricular in origin until proven otherwise, especially in older patients or those with structural heart disease. Antiarrhythmic agents such as amiodarone or procainamide are commonly used, while caution is required with AV nodal blocking agents in the presence of accessory pathways. Torsades de pointes is treated with intravenous magnesium and correction of underlying electrolyte abnormalities.
Patients with serious arrhythmias such as VT, VF, persistent SVT, or suspected cardiac ischemia require hospital admission and monitoring. Those with transient, well-tolerated supraventricular rhythms that resolve without complications may be discharged with appropriate follow-up. Prompt recognition and appropriate management are critical, as tachydysrhythmias can rapidly progress to life-threatening conditions if untreated.
Tachydysrhythmias refer to any disturbance of cardiac rhythm resulting in a heart rate greater than 100 beats per minute. They encompass a broad spectrum of arrhythmias originating from different parts of the cardiac conduction system, ranging from relatively benign sinus tachycardia to life-threatening ventricular fibrillation. The classification is typically based on the origin of the rhythm and the width of the QRS complex, distinguishing between supraventricular and ventricular causes.
Sinus tachycardia is a narrow-complex, regular rhythm usually between 100 and 150 beats per minute and represents a physiologic response to stressors such as hypovolemia, hypoxia, pain, anxiety, infection, or anemia. It results from increased sympathetic activity or reduced vagal tone and should prompt evaluation for an underlying cause rather than primary rhythm management.
Supraventricular tachycardias (SVTs) originate above the His bundle and may be regular or irregular. Regular SVTs include atrial tachycardia and junctional tachycardia, while irregular SVTs include atrial fibrillation, atrial flutter, and multifocal atrial tachycardia. Atrial fibrillation is the most common pathologic SVT encountered in emergency settings and is characterized by an irregularly irregular rhythm without distinct P waves. Atrial flutter typically demonstrates a sawtooth pattern on ECG. These rhythms are often associated with conditions such as hypertension, coronary artery disease, valvular disease, pulmonary disorders, or metabolic abnormalities.
Ventricular tachycardia (VT) is defined as three or more consecutive ventricular beats at a rate exceeding 100 beats per minute and is commonly associated with structural heart disease, particularly prior myocardial infarction. It may present as monomorphic or polymorphic VT and can rapidly deteriorate into ventricular fibrillation (VF), a chaotic rhythm with no effective cardiac output and a leading cause of sudden cardiac death. Torsades de pointes is a specific form of polymorphic VT associated with prolonged QT interval and is often triggered by medications or electrolyte imbalances such as hypokalemia or hypomagnesemia.
Clinical presentation varies widely, ranging from asymptomatic episodes to severe symptoms such as palpitations, dizziness, dyspnea, chest pain, syncope, or cardiac arrest. Signs of hemodynamic instability include hypotension, altered mental status, chest pain, and pulmonary edema, and these findings necessitate immediate intervention. A careful history and physical examination should focus on identifying underlying cardiac disease, triggers, and the stability of the patient.
Evaluation begins with assessment of airway, breathing, and circulation, followed by rapid determination of whether the patient is stable or unstable. A 12-lead ECG is essential to classify the rhythm and guide management. Laboratory testing is directed toward identifying underlying causes such as electrolyte disturbances, ischemia, or metabolic abnormalities.
Management depends primarily on the patient’s hemodynamic status and the type of rhythm. Unstable patients require immediate synchronized cardioversion for most tachydysrhythmias or defibrillation in cases of pulseless VT or VF, following advanced cardiac life support protocols. Stable patients with narrow-complex tachycardias may respond to vagal maneuvers or pharmacologic therapy such as adenosine. Atrial fibrillation and flutter are typically managed with rate control using beta-blockers or calcium channel blockers, with consideration of anticoagulation depending on duration and risk factors.
Wide-complex tachycardias should be presumed to be ventricular in origin until proven otherwise, especially in older patients or those with structural heart disease. Antiarrhythmic agents such as amiodarone or procainamide are commonly used, while caution is required with AV nodal blocking agents in the presence of accessory pathways. Torsades de pointes is treated with intravenous magnesium and correction of underlying electrolyte abnormalities.
Patients with serious arrhythmias such as VT, VF, persistent SVT, or suspected cardiac ischemia require hospital admission and monitoring. Those with transient, well-tolerated supraventricular rhythms that resolve without complications may be discharged with appropriate follow-up. Prompt recognition and appropriate management are critical, as tachydysrhythmias can rapidly progress to life-threatening conditions if untreated.
- Published on
Emergency and Acute Medicine - Taser Injuries
Taser injuries result from exposure to conducted energy weapons (CEWs), which are designed as less-lethal tools commonly used in law enforcement. These devices deliver a high-voltage, low-amperage electrical current that disrupts voluntary control of skeletal muscles, leading to temporary incapacitation and pain. Some devices require direct contact with the skin, while others fire barbed probes connected by wires that can deliver electrical current from a distance. The physiologic effects depend on factors such as probe placement, distance between probes, duration of exposure, and the individual’s underlying condition.
Cutaneous effects are the most common and typically include small puncture wounds from the barbed probes and localized skin marks referred to as “signature marks.” Although usually minor, deeper penetration can occur, particularly in sensitive areas such as the eyes, face, neck, or genitals, where underlying structures may be at risk. Skeletal injuries may occur as secondary trauma, most often due to falls following incapacitation, and can include fractures such as vertebral compression injuries. Muscle effects include strains and, in rare cases, rhabdomyolysis, especially with prolonged or repeated exposure or when associated with underlying conditions such as excited delirium syndrome (ExDS).
Cardiovascular effects are generally minimal in healthy individuals, with little evidence of significant ECG changes or myocardial injury. However, there is a theoretical risk of arrhythmias, including ventricular fibrillation, particularly if the electrical discharge occurs over the heart during a vulnerable phase of the cardiac cycle. Rare cases of atrial fibrillation have been reported. In patients with implanted cardiac devices such as pacemakers or defibrillators, the electrical activity from a CEW may be misinterpreted, potentially triggering device responses.
Neurologic complications are uncommon but can include seizures or, rarely, direct penetration injuries such as skull involvement. Respiratory compromise was initially a concern, but studies suggest that ventilation is generally maintained or even increased during CEW exposure. The overall clinical picture may also be influenced by the circumstances leading to CEW use, particularly in individuals with agitation or excited delirium, which itself carries significant morbidity and mortality.
Evaluation begins with a focused history, including the type of device used, number and duration of electrical discharges, and the location of probe contact. Physical examination should carefully assess probe entry sites and screen for secondary injuries from falls or muscle contractions. Particular attention should be paid to high-risk areas such as the eyes, neck, and groin. In patients who are alert, stable, and asymptomatic, extensive testing is generally not required. Investigations should instead be guided by clinical findings or underlying conditions, such as suspected trauma, altered mental status, or signs of excited delirium.
Management is primarily supportive and directed at associated injuries rather than the electrical exposure itself. In stable patients with no complications, treatment consists of probe removal, local wound care, and tetanus prophylaxis if indicated. Probe removal involves stabilizing the surrounding skin and applying steady traction to extract the barb. Patients with agitation or suspected excited delirium require prompt sedation and supportive care. Cardiac monitoring and further evaluation are indicated if arrhythmias or underlying cardiac disease are suspected.
Disposition depends on clinical status. Patients who are alert, hemodynamically stable, and without significant injury can be discharged after appropriate wound care and observation. Admission is required for those with cardiac instability, serious traumatic injuries, or excited delirium syndrome. Special consideration should be given to vulnerable populations such as pregnant patients, who may require fetal monitoring, and individuals with implanted cardiac devices.
A key consideration in these cases is the recognition of secondary injuries and underlying conditions rather than focusing solely on the CEW exposure. Patients presenting after Taser use should be carefully assessed for trauma, intoxication, or excited delirium, as these factors often contribute more significantly to morbidity than the electrical exposure itself.
Taser injuries result from exposure to conducted energy weapons (CEWs), which are designed as less-lethal tools commonly used in law enforcement. These devices deliver a high-voltage, low-amperage electrical current that disrupts voluntary control of skeletal muscles, leading to temporary incapacitation and pain. Some devices require direct contact with the skin, while others fire barbed probes connected by wires that can deliver electrical current from a distance. The physiologic effects depend on factors such as probe placement, distance between probes, duration of exposure, and the individual’s underlying condition.
Cutaneous effects are the most common and typically include small puncture wounds from the barbed probes and localized skin marks referred to as “signature marks.” Although usually minor, deeper penetration can occur, particularly in sensitive areas such as the eyes, face, neck, or genitals, where underlying structures may be at risk. Skeletal injuries may occur as secondary trauma, most often due to falls following incapacitation, and can include fractures such as vertebral compression injuries. Muscle effects include strains and, in rare cases, rhabdomyolysis, especially with prolonged or repeated exposure or when associated with underlying conditions such as excited delirium syndrome (ExDS).
Cardiovascular effects are generally minimal in healthy individuals, with little evidence of significant ECG changes or myocardial injury. However, there is a theoretical risk of arrhythmias, including ventricular fibrillation, particularly if the electrical discharge occurs over the heart during a vulnerable phase of the cardiac cycle. Rare cases of atrial fibrillation have been reported. In patients with implanted cardiac devices such as pacemakers or defibrillators, the electrical activity from a CEW may be misinterpreted, potentially triggering device responses.
Neurologic complications are uncommon but can include seizures or, rarely, direct penetration injuries such as skull involvement. Respiratory compromise was initially a concern, but studies suggest that ventilation is generally maintained or even increased during CEW exposure. The overall clinical picture may also be influenced by the circumstances leading to CEW use, particularly in individuals with agitation or excited delirium, which itself carries significant morbidity and mortality.
Evaluation begins with a focused history, including the type of device used, number and duration of electrical discharges, and the location of probe contact. Physical examination should carefully assess probe entry sites and screen for secondary injuries from falls or muscle contractions. Particular attention should be paid to high-risk areas such as the eyes, neck, and groin. In patients who are alert, stable, and asymptomatic, extensive testing is generally not required. Investigations should instead be guided by clinical findings or underlying conditions, such as suspected trauma, altered mental status, or signs of excited delirium.
Management is primarily supportive and directed at associated injuries rather than the electrical exposure itself. In stable patients with no complications, treatment consists of probe removal, local wound care, and tetanus prophylaxis if indicated. Probe removal involves stabilizing the surrounding skin and applying steady traction to extract the barb. Patients with agitation or suspected excited delirium require prompt sedation and supportive care. Cardiac monitoring and further evaluation are indicated if arrhythmias or underlying cardiac disease are suspected.
Disposition depends on clinical status. Patients who are alert, hemodynamically stable, and without significant injury can be discharged after appropriate wound care and observation. Admission is required for those with cardiac instability, serious traumatic injuries, or excited delirium syndrome. Special consideration should be given to vulnerable populations such as pregnant patients, who may require fetal monitoring, and individuals with implanted cardiac devices.
A key consideration in these cases is the recognition of secondary injuries and underlying conditions rather than focusing solely on the CEW exposure. Patients presenting after Taser use should be carefully assessed for trauma, intoxication, or excited delirium, as these factors often contribute more significantly to morbidity than the electrical exposure itself.
